title: Toxoplasmosis in wallabies (Macropus rufogriseus and Macropus eugenii): blindness, treatment with atovaquone, and isolation of Toxoplasma gondii.
abstract: Australasian marsupials, especially wallabies, are highly susceptible to clinical toxoplasmosis. This paper describes the use of atovaquone for effective treatment of toxoplasmosis in 4 Bennett's wallabies (Macropus rufogriseus), along with the serology, isolation of Toxoplasma gondii, and genotyping of 3 T. gondii isolates from 5 captive wallabies. This is the first report of success in treating acute toxoplasmosis in wallabies, the first report of serology followed over a significant period of time, and the first report of isolation and genetic typing of T. gondii from wallabies in the United States.
authors.affiliation: United States Department of Agriculture, Agricultural Research Service, Animal and Natural Resources Institute, Animal Parasitic Diseases Laboratory, Beltsville, Maryland 20705-2350, USA. jitender.dubey@ars.usda.gov
authors.forename: J P
authors.initials: JP
authors.lastname: Dubey
authors.forename: C
authors.initials: C
authors.lastname: Crutchley
mesh_terms: D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D053626:Atovaquone / Q000627:therapeutic use*; D001681:Biological Assay / Q000662:veterinary; D002415:Cats; D005260:Female; D007614:Macropodidae / Q000469:parasitology*; D008297:Male; D051379:Mice; D014122:Toxoplasma / Q000302:isolation & purification*; D014124:Toxoplasmosis, Animal / Q000188:drug therapy* / Q000469:parasitology; D014126:Toxoplasmosis, Ocular / Q000188:drug therapy / Q000469:parasitology / Q000662:veterinary*
chemical_list: D000890:Anti-Infective Agents; D053626:Atovaquone